Gunderson Dettmer advised Cure Ventures on the deal. Cure Ventures announced the formation of its $350 million inaugural fund. Cure Ventures invests in early-stage life sciences...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here